Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Lymphocytic, Chronic, B-Cell | 74 | 2024 | 1644 | 13.970 |
Why?
|
Cancer Vaccines | 25 | 2024 | 1044 | 5.390 |
Why?
|
Antigens, Neoplasm | 36 | 2024 | 2003 | 5.170 |
Why?
|
Hematopoietic Stem Cell Transplantation | 40 | 2024 | 5708 | 3.430 |
Why?
|
Immunotherapy | 26 | 2024 | 4728 | 2.530 |
Why?
|
Single-Cell Analysis | 18 | 2024 | 2531 | 2.330 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 10 | 2024 | 1427 | 2.300 |
Why?
|
T-Lymphocytes | 29 | 2024 | 10269 | 2.150 |
Why?
|
Neoplasms | 45 | 2024 | 22389 | 2.100 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 15 | 2013 | 687 | 2.070 |
Why?
|
Lymphocyte Transfusion | 12 | 2021 | 232 | 2.020 |
Why?
|
Mutation | 52 | 2024 | 30235 | 1.980 |
Why?
|
Leukemia, Myeloid, Acute | 10 | 2024 | 3623 | 1.720 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 14 | 2022 | 1104 | 1.670 |
Why?
|
B-Lymphocytes | 24 | 2024 | 4779 | 1.590 |
Why?
|
CD8-Positive T-Lymphocytes | 21 | 2024 | 4613 | 1.570 |
Why?
|
Leukemia | 7 | 2024 | 1527 | 1.530 |
Why?
|
Immunotherapy, Adoptive | 12 | 2024 | 1505 | 1.510 |
Why?
|
Transplantation, Homologous | 24 | 2024 | 4834 | 1.510 |
Why?
|
Graft vs Leukemia Effect | 9 | 2024 | 121 | 1.430 |
Why?
|
Gene Expression Regulation, Leukemic | 9 | 2024 | 656 | 1.400 |
Why?
|
DNA, Mitochondrial | 4 | 2024 | 871 | 1.380 |
Why?
|
Hematologic Neoplasms | 11 | 2021 | 1905 | 1.320 |
Why?
|
Sulfonamides | 5 | 2022 | 1988 | 1.320 |
Why?
|
DNA, Neoplasm | 4 | 2020 | 1749 | 1.300 |
Why?
|
Melanoma | 15 | 2024 | 5740 | 1.270 |
Why?
|
Tumor Escape | 5 | 2020 | 374 | 1.260 |
Why?
|
High-Throughput Nucleotide Sequencing | 13 | 2024 | 3669 | 1.150 |
Why?
|
Gene Expression Regulation, Neoplastic | 17 | 2024 | 8636 | 1.050 |
Why?
|
Pyrimidines | 12 | 2020 | 3050 | 1.050 |
Why?
|
Graft vs Host Disease | 18 | 2024 | 3042 | 1.010 |
Why?
|
CD4-Positive T-Lymphocytes | 12 | 2024 | 4403 | 0.980 |
Why?
|
Histocompatibility Antigens Class I | 6 | 2021 | 1355 | 0.970 |
Why?
|
Bone Marrow Transplantation | 14 | 2023 | 2702 | 0.970 |
Why?
|
Tumor Microenvironment | 20 | 2024 | 3939 | 0.960 |
Why?
|
Humans | 254 | 2025 | 768369 | 0.950 |
Why?
|
Genomics | 20 | 2024 | 5912 | 0.940 |
Why?
|
Phosphoproteins | 8 | 2023 | 2450 | 0.930 |
Why?
|
DNA Barcoding, Taxonomic | 2 | 2023 | 134 | 0.920 |
Why?
|
Gene Expression Profiling | 17 | 2024 | 9508 | 0.910 |
Why?
|
Pyrazoles | 6 | 2020 | 2024 | 0.910 |
Why?
|
Alternative Splicing | 5 | 2020 | 1094 | 0.910 |
Why?
|
Protein Array Analysis | 6 | 2012 | 399 | 0.900 |
Why?
|
Receptors, Antigen, T-Cell | 11 | 2024 | 2564 | 0.880 |
Why?
|
Transplantation Chimera | 7 | 2008 | 594 | 0.850 |
Why?
|
Carcinoma, Renal Cell | 10 | 2023 | 3198 | 0.830 |
Why?
|
Epitopes | 6 | 2021 | 2523 | 0.830 |
Why?
|
Antigen Presentation | 9 | 2023 | 1247 | 0.830 |
Why?
|
Drug Resistance, Neoplasm | 13 | 2024 | 5342 | 0.830 |
Why?
|
Evolution, Molecular | 5 | 2019 | 1894 | 0.820 |
Why?
|
Sequence Analysis, DNA | 7 | 2020 | 4774 | 0.800 |
Why?
|
Ikaros Transcription Factor | 2 | 2021 | 233 | 0.770 |
Why?
|
Neoplasm Recurrence, Local | 11 | 2023 | 9425 | 0.730 |
Why?
|
Data Mining | 4 | 2013 | 561 | 0.730 |
Why?
|
Disease Progression | 9 | 2023 | 13643 | 0.690 |
Why?
|
Protein-Tyrosine Kinases | 6 | 2023 | 2433 | 0.690 |
Why?
|
Epigenesis, Genetic | 9 | 2023 | 3832 | 0.680 |
Why?
|
Lymphoproliferative Disorders | 1 | 2023 | 531 | 0.670 |
Why?
|
HLA Antigens | 10 | 2022 | 1333 | 0.670 |
Why?
|
Spliceosomes | 3 | 2018 | 117 | 0.660 |
Why?
|
Myelodysplastic Syndromes | 4 | 2024 | 1400 | 0.650 |
Why?
|
Glioblastoma | 8 | 2025 | 3524 | 0.650 |
Why?
|
Quinazolinones | 3 | 2019 | 222 | 0.650 |
Why?
|
Anemia, Sickle Cell | 6 | 2019 | 1065 | 0.640 |
Why?
|
Receptors, Notch | 2 | 2021 | 752 | 0.640 |
Why?
|
Epitopes, T-Lymphocyte | 5 | 2014 | 822 | 0.640 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2023 | 2847 | 0.640 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 9 | 2022 | 11844 | 0.630 |
Why?
|
Lymphocyte Activation | 7 | 2024 | 5490 | 0.620 |
Why?
|
Kidney Neoplasms | 8 | 2022 | 4299 | 0.620 |
Why?
|
Neoplasm Proteins | 6 | 2021 | 3611 | 0.620 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2018 | 87 | 0.620 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2023 | 1376 | 0.610 |
Why?
|
Epoxy Compounds | 1 | 2018 | 137 | 0.600 |
Why?
|
RNA, Neoplasm | 1 | 2020 | 751 | 0.590 |
Why?
|
Stem Cell Transplantation | 3 | 2021 | 1602 | 0.590 |
Why?
|
Lymphocyte Depletion | 4 | 2013 | 605 | 0.590 |
Why?
|
Adoptive Transfer | 1 | 2020 | 825 | 0.570 |
Why?
|
Purines | 3 | 2019 | 614 | 0.570 |
Why?
|
Macrolides | 1 | 2018 | 205 | 0.570 |
Why?
|
Substrate Specificity | 1 | 2021 | 1775 | 0.560 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2021 | 998 | 0.550 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2023 | 1409 | 0.550 |
Why?
|
Melanoma-Specific Antigens | 2 | 2018 | 74 | 0.540 |
Why?
|
Receptors, Antigen, B-Cell | 4 | 2023 | 545 | 0.540 |
Why?
|
Chromatin | 6 | 2023 | 2973 | 0.540 |
Why?
|
Mice | 38 | 2024 | 82051 | 0.540 |
Why?
|
Animals | 53 | 2024 | 169424 | 0.520 |
Why?
|
Mitochondria | 5 | 2023 | 3672 | 0.510 |
Why?
|
Adenine | 7 | 2022 | 993 | 0.500 |
Why?
|
Peptides | 7 | 2022 | 4368 | 0.500 |
Why?
|
Epigenomics | 3 | 2017 | 958 | 0.500 |
Why?
|
Clone Cells | 7 | 2022 | 1672 | 0.490 |
Why?
|
Antigens, Surface | 3 | 2010 | 1615 | 0.470 |
Why?
|
Fusion Proteins, bcr-abl | 6 | 2012 | 430 | 0.460 |
Why?
|
Validation Studies as Topic | 2 | 2012 | 162 | 0.450 |
Why?
|
Monitoring, Immunologic | 4 | 2021 | 100 | 0.450 |
Why?
|
Ribonucleoprotein, U2 Small Nuclear | 1 | 2013 | 20 | 0.440 |
Why?
|
Databases, Genetic | 6 | 2019 | 1754 | 0.420 |
Why?
|
Cell Lineage | 6 | 2024 | 2575 | 0.420 |
Why?
|
Skin Neoplasms | 7 | 2023 | 5891 | 0.420 |
Why?
|
Piperidines | 7 | 2022 | 1664 | 0.410 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1796 | 0.410 |
Why?
|
Oncolytic Virotherapy | 1 | 2018 | 521 | 0.410 |
Why?
|
Tissue Donors | 8 | 2024 | 2377 | 0.400 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2017 | 776 | 0.400 |
Why?
|
Erythropoiesis | 4 | 2016 | 694 | 0.390 |
Why?
|
DNA Methylation | 9 | 2021 | 4425 | 0.390 |
Why?
|
Tandem Mass Spectrometry | 2 | 2021 | 1197 | 0.380 |
Why?
|
Transplantation Conditioning | 5 | 2013 | 1598 | 0.380 |
Why?
|
Base Sequence | 4 | 2020 | 12426 | 0.380 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2023 | 3619 | 0.370 |
Why?
|
Transcription, Genetic | 5 | 2021 | 7602 | 0.370 |
Why?
|
Algorithms | 10 | 2020 | 14157 | 0.370 |
Why?
|
Recurrence | 11 | 2023 | 8510 | 0.360 |
Why?
|
Cell Line, Tumor | 14 | 2024 | 17149 | 0.360 |
Why?
|
Antineoplastic Agents | 14 | 2023 | 13709 | 0.360 |
Why?
|
Signal Transduction | 15 | 2023 | 23639 | 0.350 |
Why?
|
Polyomavirus Infections | 2 | 2023 | 193 | 0.350 |
Why?
|
Germ-Line Mutation | 2 | 2018 | 1884 | 0.350 |
Why?
|
Leukocytes, Mononuclear | 5 | 2022 | 1852 | 0.350 |
Why?
|
Education | 1 | 2013 | 536 | 0.340 |
Why?
|
beta Catenin | 2 | 2015 | 1048 | 0.340 |
Why?
|
Tumor Cells, Cultured | 9 | 2022 | 6135 | 0.340 |
Why?
|
DNA Copy Number Variations | 7 | 2021 | 2046 | 0.340 |
Why?
|
K562 Cells | 5 | 2013 | 645 | 0.330 |
Why?
|
Ploidies | 2 | 2024 | 287 | 0.330 |
Why?
|
Antigen-Antibody Complex | 1 | 2011 | 511 | 0.320 |
Why?
|
Databases, Protein | 3 | 2019 | 387 | 0.320 |
Why?
|
Protein Kinase Inhibitors | 7 | 2023 | 5709 | 0.320 |
Why?
|
Disease Models, Animal | 6 | 2023 | 18390 | 0.320 |
Why?
|
Female | 76 | 2025 | 396926 | 0.320 |
Why?
|
Toll-Like Receptors | 2 | 2020 | 581 | 0.320 |
Why?
|
Middle Aged | 54 | 2025 | 223406 | 0.320 |
Why?
|
Male | 65 | 2025 | 364761 | 0.310 |
Why?
|
Immunoprecipitation | 1 | 2011 | 876 | 0.310 |
Why?
|
Carcinoma, Merkel Cell | 2 | 2023 | 331 | 0.300 |
Why?
|
Hemolysis | 2 | 2007 | 419 | 0.300 |
Why?
|
Vaccination | 8 | 2024 | 3433 | 0.290 |
Why?
|
Congresses as Topic | 1 | 2012 | 810 | 0.290 |
Why?
|
Apoptosis | 9 | 2023 | 9526 | 0.290 |
Why?
|
Adult | 49 | 2025 | 223528 | 0.280 |
Why?
|
Immunity | 2 | 2023 | 1002 | 0.280 |
Why?
|
Protein Interaction Mapping | 1 | 2011 | 617 | 0.280 |
Why?
|
Immunophenotyping | 3 | 2022 | 1868 | 0.280 |
Why?
|
Mice, Inbred NOD | 2 | 2021 | 1840 | 0.270 |
Why?
|
Genomic Instability | 3 | 2021 | 714 | 0.270 |
Why?
|
Erythroid Cells | 1 | 2008 | 238 | 0.270 |
Why?
|
Immunologic Memory | 4 | 2021 | 1371 | 0.270 |
Why?
|
Indoles | 1 | 2014 | 1834 | 0.270 |
Why?
|
Phenotype | 6 | 2024 | 16712 | 0.260 |
Why?
|
Mice, Transgenic | 6 | 2023 | 9558 | 0.260 |
Why?
|
Genetic Heterogeneity | 4 | 2024 | 738 | 0.260 |
Why?
|
Genome | 1 | 2014 | 1750 | 0.260 |
Why?
|
beta-Thalassemia | 1 | 2008 | 236 | 0.250 |
Why?
|
Piperazines | 6 | 2020 | 2546 | 0.250 |
Why?
|
Neuroblastoma | 2 | 2024 | 1265 | 0.250 |
Why?
|
Prognosis | 16 | 2024 | 30031 | 0.250 |
Why?
|
Minor Histocompatibility Antigens | 2 | 2021 | 302 | 0.250 |
Why?
|
T-Lymphocytes, Cytotoxic | 5 | 2024 | 1786 | 0.240 |
Why?
|
Neoplasms, Experimental | 2 | 2021 | 1232 | 0.240 |
Why?
|
Erythroblasts | 1 | 2005 | 142 | 0.240 |
Why?
|
Antigen-Presenting Cells | 5 | 2023 | 964 | 0.240 |
Why?
|
Myeloid Progenitor Cells | 1 | 2005 | 112 | 0.240 |
Why?
|
Cell Communication | 3 | 2024 | 1662 | 0.240 |
Why?
|
Computational Biology | 6 | 2020 | 3549 | 0.240 |
Why?
|
Graft Survival | 5 | 2011 | 3890 | 0.230 |
Why?
|
Siblings | 1 | 2008 | 829 | 0.230 |
Why?
|
Proteome | 4 | 2019 | 1881 | 0.230 |
Why?
|
Cytokines | 5 | 2023 | 7440 | 0.230 |
Why?
|
Models, Biological | 2 | 2019 | 9505 | 0.230 |
Why?
|
Genetic Variation | 3 | 2015 | 6607 | 0.230 |
Why?
|
Living Donors | 1 | 2008 | 651 | 0.220 |
Why?
|
Sequence Analysis, RNA | 6 | 2024 | 2038 | 0.220 |
Why?
|
Immune System | 6 | 2022 | 801 | 0.220 |
Why?
|
NF-kappa B | 2 | 2023 | 2491 | 0.220 |
Why?
|
Polymerase Chain Reaction | 7 | 2019 | 6087 | 0.220 |
Why?
|
MELAS Syndrome | 1 | 2024 | 56 | 0.220 |
Why?
|
Genome, Human | 6 | 2023 | 4454 | 0.220 |
Why?
|
Isoantigens | 1 | 2006 | 563 | 0.220 |
Why?
|
Antibodies, Neoplasm | 3 | 2002 | 283 | 0.210 |
Why?
|
Herpesvirus 6, Human | 1 | 2023 | 98 | 0.210 |
Why?
|
Genes, myc | 2 | 2015 | 391 | 0.210 |
Why?
|
RNA Splicing | 3 | 2018 | 906 | 0.210 |
Why?
|
Gene Library | 5 | 2011 | 1064 | 0.210 |
Why?
|
Immunity, Innate | 3 | 2022 | 3076 | 0.210 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2024 | 706 | 0.200 |
Why?
|
Treatment Outcome | 15 | 2024 | 65408 | 0.200 |
Why?
|
Periodicals as Topic | 2 | 2012 | 1468 | 0.200 |
Why?
|
Cell-Penetrating Peptides | 1 | 2022 | 45 | 0.200 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2024 | 762 | 0.200 |
Why?
|
Antigens, CD34 | 1 | 2024 | 656 | 0.200 |
Why?
|
RNA, Messenger | 7 | 2022 | 12813 | 0.200 |
Why?
|
Blood | 1 | 2024 | 597 | 0.200 |
Why?
|
Endogenous Retroviruses | 2 | 2020 | 112 | 0.190 |
Why?
|
Neoplastic Stem Cells | 1 | 2010 | 1357 | 0.190 |
Why?
|
Multiple Myeloma | 5 | 2015 | 5193 | 0.190 |
Why?
|
Virus Activation | 1 | 2023 | 322 | 0.190 |
Why?
|
Statistics as Topic | 1 | 2008 | 2362 | 0.190 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2023 | 2884 | 0.190 |
Why?
|
Down-Regulation | 2 | 2020 | 2942 | 0.190 |
Why?
|
Graft vs Host Reaction | 1 | 2021 | 99 | 0.190 |
Why?
|
Daptomycin | 1 | 2021 | 71 | 0.190 |
Why?
|
Aged | 30 | 2025 | 171514 | 0.190 |
Why?
|
High-Throughput Screening Assays | 2 | 2020 | 939 | 0.180 |
Why?
|
Antibodies, Monoclonal | 4 | 2022 | 9261 | 0.180 |
Why?
|
Transplantation, Autologous | 3 | 2021 | 2126 | 0.180 |
Why?
|
Proteomics | 5 | 2024 | 3901 | 0.180 |
Why?
|
Pyrimethamine | 1 | 2021 | 94 | 0.180 |
Why?
|
Virus Latency | 1 | 2023 | 359 | 0.180 |
Why?
|
Treatment Failure | 2 | 2024 | 2655 | 0.180 |
Why?
|
Cell Tracking | 1 | 2022 | 140 | 0.180 |
Why?
|
Genome-Wide Association Study | 3 | 2019 | 12771 | 0.180 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2023 | 5426 | 0.180 |
Why?
|
Social Sciences | 1 | 2020 | 40 | 0.170 |
Why?
|
Aged, 80 and over | 14 | 2024 | 59679 | 0.170 |
Why?
|
Tumor Virus Infections | 1 | 2023 | 438 | 0.170 |
Why?
|
Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2000 | 67 | 0.170 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2000 | 70 | 0.170 |
Why?
|
Therapies, Investigational | 1 | 2021 | 111 | 0.170 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2023 | 1614 | 0.170 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2022 | 258 | 0.170 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2021 | 720 | 0.170 |
Why?
|
Leukemia, Myeloid | 2 | 2021 | 693 | 0.170 |
Why?
|
Cells, Cultured | 7 | 2020 | 19035 | 0.170 |
Why?
|
Chemokines | 1 | 2024 | 963 | 0.170 |
Why?
|
Cell Proliferation | 4 | 2021 | 10490 | 0.170 |
Why?
|
Technology | 1 | 2022 | 296 | 0.170 |
Why?
|
Lung Neoplasms | 6 | 2023 | 13589 | 0.160 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2022 | 325 | 0.160 |
Why?
|
CpG Islands | 3 | 2024 | 1211 | 0.160 |
Why?
|
Rhabdoid Tumor | 1 | 2021 | 210 | 0.160 |
Why?
|
Cell Differentiation | 5 | 2022 | 11674 | 0.150 |
Why?
|
RNA Polymerase III | 1 | 2018 | 59 | 0.150 |
Why?
|
Small Ubiquitin-Related Modifier Proteins | 1 | 2018 | 68 | 0.150 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 3 | 2020 | 906 | 0.150 |
Why?
|
Antigens, CD19 | 4 | 2024 | 437 | 0.150 |
Why?
|
Blotting, Western | 4 | 2011 | 5042 | 0.150 |
Why?
|
Immunity, Cellular | 2 | 2014 | 1559 | 0.150 |
Why?
|
Chromosome Deletion | 4 | 2020 | 1390 | 0.150 |
Why?
|
Organoids | 1 | 2024 | 750 | 0.150 |
Why?
|
Neoplasm Transplantation | 1 | 2021 | 2017 | 0.150 |
Why?
|
Immunoglobulin Variable Region | 3 | 2023 | 420 | 0.140 |
Why?
|
Phospholipase C gamma | 1 | 2017 | 131 | 0.140 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2014 | 4582 | 0.140 |
Why?
|
Gene Expression Regulation | 5 | 2023 | 11928 | 0.140 |
Why?
|
Benzamides | 5 | 2012 | 1381 | 0.140 |
Why?
|
Chromatography, Liquid | 2 | 2021 | 998 | 0.140 |
Why?
|
Oxidative Phosphorylation | 1 | 2019 | 501 | 0.140 |
Why?
|
Cloning, Molecular | 3 | 2019 | 4174 | 0.140 |
Why?
|
Introns | 1 | 2020 | 971 | 0.140 |
Why?
|
Flow Cytometry | 4 | 2022 | 5893 | 0.140 |
Why?
|
HEK293 Cells | 2 | 2018 | 4294 | 0.140 |
Why?
|
Viral Envelope Proteins | 1 | 2020 | 641 | 0.140 |
Why?
|
Jurkat Cells | 1 | 2018 | 743 | 0.140 |
Why?
|
Myocarditis | 1 | 2024 | 804 | 0.140 |
Why?
|
Biological Products | 2 | 2024 | 937 | 0.140 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2020 | 1438 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 18047 | 0.140 |
Why?
|
Hematopoiesis | 2 | 2023 | 2058 | 0.140 |
Why?
|
Dendritic Cells | 6 | 2024 | 2753 | 0.140 |
Why?
|
Pericardial Effusion | 1 | 1998 | 247 | 0.130 |
Why?
|
Epidemiology | 1 | 2019 | 280 | 0.130 |
Why?
|
Survival Rate | 6 | 2021 | 12875 | 0.130 |
Why?
|
Drug Monitoring | 1 | 2002 | 964 | 0.130 |
Why?
|
STAT3 Transcription Factor | 1 | 2021 | 873 | 0.130 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2020 | 1688 | 0.130 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 757 | 0.130 |
Why?
|
Hemangiosarcoma | 1 | 1998 | 216 | 0.130 |
Why?
|
Mice, SCID | 1 | 2021 | 2633 | 0.130 |
Why?
|
Receptor, Notch1 | 1 | 2019 | 521 | 0.130 |
Why?
|
Bayes Theorem | 1 | 2024 | 2359 | 0.130 |
Why?
|
Software | 6 | 2023 | 4465 | 0.130 |
Why?
|
Receptors, Immunologic | 1 | 2022 | 1411 | 0.130 |
Why?
|
Pathology, Molecular | 1 | 2019 | 329 | 0.130 |
Why?
|
Histiocytic Sarcoma | 1 | 2016 | 40 | 0.130 |
Why?
|
Cell Line | 6 | 2023 | 15610 | 0.130 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 2020 | 410 | 0.130 |
Why?
|
RNA Transport | 1 | 2015 | 43 | 0.130 |
Why?
|
Complementarity Determining Regions | 1 | 2016 | 150 | 0.130 |
Why?
|
Amino Acid Sequence | 6 | 2018 | 13447 | 0.130 |
Why?
|
Mice, Knockout | 5 | 2024 | 14483 | 0.130 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1760 | 0.130 |
Why?
|
Lymph Nodes | 3 | 2023 | 3472 | 0.130 |
Why?
|
Microsatellite Instability | 2 | 2018 | 726 | 0.130 |
Why?
|
Lymphoma | 2 | 2022 | 1907 | 0.130 |
Why?
|
Immunologic Surveillance | 1 | 2016 | 92 | 0.130 |
Why?
|
Immunomodulation | 1 | 2019 | 550 | 0.120 |
Why?
|
Interleukin-2 | 1 | 2022 | 1892 | 0.120 |
Why?
|
Hematopoietic Stem Cells | 3 | 2016 | 3408 | 0.120 |
Why?
|
DNA Polymerase II | 1 | 2015 | 104 | 0.120 |
Why?
|
Cyclophilin A | 1 | 2015 | 58 | 0.120 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2022 | 895 | 0.120 |
Why?
|
Cell Transdifferentiation | 1 | 2016 | 188 | 0.120 |
Why?
|
Heart Neoplasms | 1 | 1998 | 374 | 0.120 |
Why?
|
Molecular Sequence Data | 8 | 2014 | 17637 | 0.120 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2017 | 212 | 0.120 |
Why?
|
PTEN Phosphohydrolase | 2 | 2020 | 1119 | 0.120 |
Why?
|
Mutation, Missense | 3 | 2014 | 2590 | 0.120 |
Why?
|
Transplantation, Isogeneic | 2 | 2012 | 249 | 0.120 |
Why?
|
Sulfites | 1 | 2014 | 83 | 0.120 |
Why?
|
Gene Deletion | 2 | 2020 | 2674 | 0.120 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2023 | 4083 | 0.120 |
Why?
|
Biomarkers, Pharmacological | 1 | 2015 | 162 | 0.120 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2017 | 452 | 0.120 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2014 | 3793 | 0.120 |
Why?
|
Lymphocytes | 3 | 2012 | 2611 | 0.120 |
Why?
|
Case-Control Studies | 6 | 2024 | 22286 | 0.120 |
Why?
|
Remission Induction | 4 | 2012 | 2408 | 0.120 |
Why?
|
Immunosuppressive Agents | 3 | 2018 | 4213 | 0.120 |
Why?
|
Neoadjuvant Therapy | 2 | 2023 | 2896 | 0.110 |
Why?
|
Thiophenes | 1 | 2018 | 570 | 0.110 |
Why?
|
Soft Tissue Neoplasms | 1 | 2023 | 1166 | 0.110 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2021 | 16023 | 0.110 |
Why?
|
Oncogenes | 2 | 2024 | 1235 | 0.110 |
Why?
|
Vaccines | 1 | 2022 | 845 | 0.110 |
Why?
|
Protein Multimerization | 1 | 2018 | 979 | 0.110 |
Why?
|
Mutant Proteins | 2 | 2018 | 489 | 0.110 |
Why?
|
Ubiquitin | 1 | 2018 | 843 | 0.110 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2020 | 934 | 0.110 |
Why?
|
Genotype | 2 | 2024 | 13045 | 0.110 |
Why?
|
Longitudinal Studies | 2 | 2021 | 14766 | 0.110 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2020 | 1092 | 0.110 |
Why?
|
Ribosomal Proteins | 1 | 2015 | 371 | 0.110 |
Why?
|
Proto-Oncogene Proteins | 4 | 2019 | 4534 | 0.110 |
Why?
|
Ecosystem | 1 | 2017 | 494 | 0.110 |
Why?
|
Combined Modality Therapy | 4 | 2022 | 8559 | 0.110 |
Why?
|
Survival Analysis | 4 | 2021 | 10127 | 0.110 |
Why?
|
Nanowires | 1 | 2012 | 31 | 0.110 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2015 | 394 | 0.110 |
Why?
|
Leiomyosarcoma | 1 | 2017 | 425 | 0.100 |
Why?
|
Antigens | 3 | 2022 | 1443 | 0.100 |
Why?
|
Histone Deacetylases | 1 | 2017 | 717 | 0.100 |
Why?
|
Telomere | 1 | 2019 | 942 | 0.100 |
Why?
|
Chromosome Aberrations | 2 | 2021 | 1781 | 0.100 |
Why?
|
Ovarian Neoplasms | 2 | 2022 | 4906 | 0.100 |
Why?
|
Transcription Factors | 5 | 2023 | 12176 | 0.100 |
Why?
|
Vaccines, Subunit | 2 | 2023 | 159 | 0.100 |
Why?
|
Nuclear Proteins | 3 | 2023 | 5808 | 0.100 |
Why?
|
Silicon | 1 | 2012 | 143 | 0.100 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2013 | 300 | 0.100 |
Why?
|
Cyclophosphamide | 3 | 2023 | 2224 | 0.100 |
Why?
|
Biopsy | 2 | 2023 | 6816 | 0.100 |
Why?
|
Sarcoma | 1 | 2023 | 1806 | 0.100 |
Why?
|
Adjuvants, Immunologic | 2 | 2020 | 998 | 0.100 |
Why?
|
Blood Donors | 1 | 2013 | 345 | 0.100 |
Why?
|
Myocardium | 1 | 2024 | 4789 | 0.100 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2016 | 480 | 0.100 |
Why?
|
Ligands | 3 | 2024 | 3279 | 0.090 |
Why?
|
Lymphocyte Count | 1 | 2013 | 791 | 0.090 |
Why?
|
Selection, Genetic | 1 | 2016 | 874 | 0.090 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2019 | 1352 | 0.090 |
Why?
|
Chemokine CCL3 | 1 | 2011 | 85 | 0.090 |
Why?
|
Cell Nucleus | 1 | 2020 | 2889 | 0.090 |
Why?
|
DNA Mutational Analysis | 4 | 2017 | 4120 | 0.090 |
Why?
|
Models, Immunological | 2 | 2014 | 516 | 0.090 |
Why?
|
Graft Rejection | 4 | 2008 | 4505 | 0.090 |
Why?
|
BRCA2 Protein | 1 | 2016 | 802 | 0.090 |
Why?
|
Databases as Topic | 1 | 2013 | 475 | 0.090 |
Why?
|
Plasma Cells | 2 | 2005 | 598 | 0.090 |
Why?
|
Carcinoma | 1 | 2022 | 2341 | 0.090 |
Why?
|
CD40 Ligand | 1 | 2012 | 524 | 0.090 |
Why?
|
Immunoglobulin Isotypes | 1 | 1991 | 158 | 0.090 |
Why?
|
Cyclosporine | 2 | 2008 | 781 | 0.090 |
Why?
|
Mice, Inbred C57BL | 4 | 2024 | 22365 | 0.090 |
Why?
|
Radionuclide Imaging | 1 | 2014 | 1998 | 0.090 |
Why?
|
Cell Compartmentation | 1 | 2011 | 383 | 0.090 |
Why?
|
Twins | 1 | 2012 | 340 | 0.090 |
Why?
|
Protein Binding | 2 | 2014 | 9376 | 0.090 |
Why?
|
Thalassemia | 1 | 2011 | 267 | 0.090 |
Why?
|
Autophagy | 1 | 2018 | 1349 | 0.090 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2010 | 71 | 0.090 |
Why?
|
Macrophages | 2 | 2024 | 5797 | 0.080 |
Why?
|
Stromal Cells | 2 | 2012 | 1335 | 0.080 |
Why?
|
Chemokine CXCL10 | 1 | 2011 | 311 | 0.080 |
Why?
|
Phylogeny | 1 | 2017 | 2841 | 0.080 |
Why?
|
Heart Transplantation | 2 | 1994 | 3291 | 0.080 |
Why?
|
Alleles | 2 | 2019 | 6880 | 0.080 |
Why?
|
B-Lymphocyte Subsets | 1 | 1991 | 240 | 0.080 |
Why?
|
Documentation | 2 | 2013 | 913 | 0.080 |
Why?
|
Tacrolimus | 2 | 2023 | 750 | 0.080 |
Why?
|
BRCA1 Protein | 1 | 2016 | 1158 | 0.080 |
Why?
|
Bone Marrow Cells | 2 | 2013 | 2415 | 0.080 |
Why?
|
Erythema | 1 | 2010 | 262 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2023 | 2915 | 0.080 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2009 | 189 | 0.080 |
Why?
|
Immunodominant Epitopes | 1 | 2010 | 239 | 0.080 |
Why?
|
Chromosomes, Human, Y | 1 | 2010 | 163 | 0.080 |
Why?
|
Killer Cells, Natural | 3 | 2023 | 2207 | 0.080 |
Why?
|
Histocompatibility | 1 | 2010 | 322 | 0.080 |
Why?
|
Interferon-alpha | 2 | 2011 | 909 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2015 | 1489 | 0.080 |
Why?
|
RNA Interference | 2 | 2014 | 2832 | 0.080 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 1734 | 0.080 |
Why?
|
Adenocarcinoma | 2 | 2016 | 6400 | 0.080 |
Why?
|
Young Adult | 10 | 2024 | 60038 | 0.080 |
Why?
|
Energy Metabolism | 1 | 2019 | 2901 | 0.080 |
Why?
|
Medical Oncology | 1 | 2020 | 2347 | 0.080 |
Why?
|
Nucleic Acids | 1 | 2011 | 190 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2023 | 1147 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2020 | 3590 | 0.080 |
Why?
|
Stem Cells | 1 | 2021 | 3538 | 0.080 |
Why?
|
rab GTP-Binding Proteins | 1 | 2010 | 244 | 0.080 |
Why?
|
Cohort Studies | 5 | 2020 | 41782 | 0.070 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2010 | 369 | 0.070 |
Why?
|
T-Lymphocyte Subsets | 1 | 2016 | 1813 | 0.070 |
Why?
|
Uterine Neoplasms | 1 | 2017 | 1423 | 0.070 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 2023 | 646 | 0.070 |
Why?
|
Myeloablative Agonists | 1 | 2008 | 210 | 0.070 |
Why?
|
Reproducibility of Results | 3 | 2019 | 20232 | 0.070 |
Why?
|
Exoribonucleases | 2 | 2005 | 90 | 0.070 |
Why?
|
Bone Marrow | 3 | 2024 | 2929 | 0.070 |
Why?
|
Melanosomes | 1 | 2007 | 33 | 0.070 |
Why?
|
Workflow | 1 | 2012 | 861 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 4 | 2021 | 2819 | 0.070 |
Why?
|
Tumor Burden | 1 | 2013 | 1909 | 0.070 |
Why?
|
Pulmonary Edema | 1 | 2010 | 409 | 0.070 |
Why?
|
Histocompatibility Testing | 2 | 2019 | 716 | 0.070 |
Why?
|
Saccharomyces cerevisiae | 1 | 2018 | 2680 | 0.070 |
Why?
|
Models, Genetic | 1 | 2017 | 3442 | 0.070 |
Why?
|
Blood Group Incompatibility | 1 | 2008 | 135 | 0.070 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6856 | 0.070 |
Why?
|
Peptide Mapping | 1 | 2007 | 260 | 0.070 |
Why?
|
src-Family Kinases | 1 | 2010 | 539 | 0.070 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2021 | 467 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 8051 | 0.070 |
Why?
|
Child | 8 | 2024 | 80856 | 0.070 |
Why?
|
Mycophenolic Acid | 1 | 2008 | 350 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 2 | 2021 | 2477 | 0.070 |
Why?
|
Immunoglobulin G | 5 | 2011 | 4570 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2834 | 0.070 |
Why?
|
Endometrial Neoplasms | 1 | 2015 | 1382 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2010 | 727 | 0.070 |
Why?
|
Time Factors | 6 | 2019 | 40271 | 0.060 |
Why?
|
Child, Preschool | 5 | 2024 | 42620 | 0.060 |
Why?
|
Organelles | 1 | 2007 | 265 | 0.060 |
Why?
|
Immunity, Humoral | 1 | 2010 | 612 | 0.060 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1514 | 0.060 |
Why?
|
H-Y Antigen | 1 | 2004 | 42 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 3 | 2021 | 6537 | 0.060 |
Why?
|
Promoter Regions, Genetic | 3 | 2019 | 5803 | 0.060 |
Why?
|
Molecular Chaperones | 1 | 2010 | 764 | 0.060 |
Why?
|
Pandemics | 2 | 2022 | 8751 | 0.060 |
Why?
|
Graft vs Tumor Effect | 1 | 2005 | 68 | 0.060 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2017 | 2254 | 0.060 |
Why?
|
Adolescent | 8 | 2024 | 89163 | 0.060 |
Why?
|
Ventricular Myosins | 1 | 2024 | 65 | 0.060 |
Why?
|
Breast Neoplasms | 2 | 2023 | 21157 | 0.060 |
Why?
|
RNA, Transfer, Leu | 1 | 2024 | 13 | 0.060 |
Why?
|
Sialoglycoproteins | 1 | 2005 | 320 | 0.060 |
Why?
|
Cell Survival | 1 | 2014 | 5800 | 0.060 |
Why?
|
Receptors, Transferrin | 1 | 2005 | 300 | 0.060 |
Why?
|
Protein Biosynthesis | 1 | 2011 | 2096 | 0.050 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3436 | 0.050 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2020 | 1322 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39429 | 0.050 |
Why?
|
Gene Expression | 5 | 2019 | 7605 | 0.050 |
Why?
|
Roseolovirus Infections | 1 | 2023 | 50 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2025 | 9177 | 0.050 |
Why?
|
Antibody Specificity | 1 | 2005 | 1063 | 0.050 |
Why?
|
Palatine Tonsil | 1 | 2023 | 193 | 0.050 |
Why?
|
STAT Transcription Factors | 1 | 2023 | 190 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2023 | 2882 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7467 | 0.050 |
Why?
|
Fever | 1 | 2010 | 1622 | 0.050 |
Why?
|
Blood Proteins | 1 | 2008 | 1183 | 0.050 |
Why?
|
Globins | 1 | 2003 | 405 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2012 | 6527 | 0.050 |
Why?
|
Bone Marrow Examination | 1 | 2002 | 155 | 0.050 |
Why?
|
Vaccines, DNA | 1 | 2024 | 280 | 0.050 |
Why?
|
Janus Kinases | 1 | 2023 | 253 | 0.050 |
Why?
|
Neoplasm Metastasis | 2 | 2024 | 4931 | 0.050 |
Why?
|
Thiazoles | 1 | 2010 | 1541 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2005 | 588 | 0.050 |
Why?
|
Response Elements | 1 | 2023 | 308 | 0.050 |
Why?
|
Cross-Priming | 1 | 2022 | 75 | 0.050 |
Why?
|
Culture Media, Conditioned | 1 | 2023 | 522 | 0.050 |
Why?
|
Interleukin-18 | 1 | 2023 | 251 | 0.050 |
Why?
|
Cytogenetic Analysis | 1 | 2002 | 270 | 0.050 |
Why?
|
bcl-X Protein | 1 | 2023 | 412 | 0.050 |
Why?
|
Antigens, Viral, Tumor | 1 | 2022 | 153 | 0.050 |
Why?
|
Prospective Studies | 5 | 2020 | 54913 | 0.050 |
Why?
|
Forkhead Transcription Factors | 1 | 2009 | 1625 | 0.050 |
Why?
|
Genetic Markers | 1 | 2008 | 2604 | 0.050 |
Why?
|
Up-Regulation | 1 | 2011 | 4132 | 0.050 |
Why?
|
Leukopoiesis | 1 | 2001 | 54 | 0.050 |
Why?
|
Chemical Fractionation | 1 | 2021 | 61 | 0.050 |
Why?
|
Organ Specificity | 2 | 2023 | 1974 | 0.050 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 2001 | 111 | 0.050 |
Why?
|
Cell Cycle Proteins | 2 | 2023 | 3464 | 0.050 |
Why?
|
Pulmonary Alveoli | 1 | 2024 | 666 | 0.050 |
Why?
|
Azacitidine | 1 | 2023 | 336 | 0.050 |
Why?
|
Erythrocytes | 1 | 2011 | 2422 | 0.050 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2023 | 435 | 0.050 |
Why?
|
Gene Frequency | 1 | 2008 | 3615 | 0.050 |
Why?
|
Telomere-Binding Proteins | 1 | 2021 | 121 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2705 | 0.050 |
Why?
|
Interferon-gamma | 2 | 2023 | 3164 | 0.040 |
Why?
|
Focal Adhesion Kinase 2 | 1 | 2000 | 87 | 0.040 |
Why?
|
Life | 1 | 2020 | 13 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2008 | 14725 | 0.040 |
Why?
|
Etoposide | 1 | 2022 | 640 | 0.040 |
Why?
|
Autoantigens | 1 | 2024 | 893 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcr | 1 | 2020 | 20 | 0.040 |
Why?
|
DNA Damage | 2 | 2021 | 2461 | 0.040 |
Why?
|
Molecular Sequence Annotation | 2 | 2012 | 527 | 0.040 |
Why?
|
Troponin I | 1 | 2024 | 662 | 0.040 |
Why?
|
HLA-A Antigens | 2 | 2011 | 223 | 0.040 |
Why?
|
HLA-A2 Antigen | 2 | 2011 | 209 | 0.040 |
Why?
|
Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2000 | 133 | 0.040 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2023 | 497 | 0.040 |
Why?
|
Troponin T | 1 | 2024 | 787 | 0.040 |
Why?
|
Ribonuclease H | 1 | 2019 | 52 | 0.040 |
Why?
|
Microscopy | 1 | 2024 | 909 | 0.040 |
Why?
|
Vincristine | 1 | 2022 | 1039 | 0.040 |
Why?
|
Freezing | 1 | 2020 | 311 | 0.040 |
Why?
|
Mice, Nude | 2 | 2020 | 3635 | 0.040 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2019 | 57 | 0.040 |
Why?
|
Protein Isoforms | 2 | 2020 | 1706 | 0.040 |
Why?
|
Incidence | 4 | 2023 | 21552 | 0.040 |
Why?
|
RNA-Binding Proteins | 2 | 2005 | 1885 | 0.040 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2020 | 370 | 0.040 |
Why?
|
DNA Transposable Elements | 1 | 2023 | 762 | 0.040 |
Why?
|
Gene Fusion | 1 | 2022 | 356 | 0.040 |
Why?
|
RNA Splice Sites | 1 | 2020 | 213 | 0.040 |
Why?
|
Genes, Suppressor | 1 | 2018 | 47 | 0.040 |
Why?
|
Drugs, Investigational | 1 | 2021 | 213 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2019 | 11139 | 0.040 |
Why?
|
Drug Repositioning | 1 | 2021 | 244 | 0.040 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2020 | 305 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2022 | 560 | 0.040 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2020 | 534 | 0.040 |
Why?
|
Retrospective Studies | 6 | 2024 | 81835 | 0.040 |
Why?
|
Histone Code | 1 | 2019 | 160 | 0.040 |
Why?
|
Mice, 129 Strain | 1 | 2019 | 370 | 0.040 |
Why?
|
DNA Modification Methylases | 1 | 2018 | 210 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2018 | 6979 | 0.040 |
Why?
|
Interleukins | 2 | 1993 | 791 | 0.040 |
Why?
|
Sumoylation | 1 | 2018 | 83 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2023 | 1021 | 0.040 |
Why?
|
DNA-Binding Proteins | 3 | 2020 | 9623 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 979 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 711 | 0.040 |
Why?
|
Adaptive Immunity | 1 | 2022 | 734 | 0.040 |
Why?
|
Histone Demethylases | 1 | 2020 | 322 | 0.040 |
Why?
|
Melanocytes | 1 | 2021 | 512 | 0.040 |
Why?
|
Automation | 1 | 2020 | 588 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2019 | 930 | 0.040 |
Why?
|
Phthalazines | 1 | 2020 | 396 | 0.040 |
Why?
|
Prednisone | 1 | 2022 | 1568 | 0.030 |
Why?
|
beta 2-Microglobulin | 1 | 2018 | 329 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 2016 | 808 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2021 | 1083 | 0.030 |
Why?
|
Blotting, Southern | 2 | 1994 | 777 | 0.030 |
Why?
|
Exons | 1 | 2023 | 2392 | 0.030 |
Why?
|
DNA Repair Enzymes | 1 | 2018 | 347 | 0.030 |
Why?
|
Biological Clocks | 1 | 2019 | 321 | 0.030 |
Why?
|
Peptide Hydrolases | 1 | 2019 | 618 | 0.030 |
Why?
|
Antibodies | 1 | 2005 | 2426 | 0.030 |
Why?
|
Immunoglobulin M | 2 | 2012 | 1528 | 0.030 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 1 | 2017 | 103 | 0.030 |
Why?
|
Neutropenia | 1 | 2022 | 892 | 0.030 |
Why?
|
Reference Values | 2 | 2003 | 4941 | 0.030 |
Why?
|
Amino Acids | 1 | 2022 | 1713 | 0.030 |
Why?
|
Cryopreservation | 1 | 2021 | 731 | 0.030 |
Why?
|
Methotrexate | 1 | 2003 | 1722 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2023 | 1277 | 0.030 |
Why?
|
Melanoma, Experimental | 1 | 2019 | 561 | 0.030 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2012 | 453 | 0.030 |
Why?
|
Sirolimus | 1 | 2003 | 1542 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1628 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 2019 | 798 | 0.030 |
Why?
|
Oncolytic Viruses | 1 | 2020 | 345 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2019 | 1755 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2018 | 663 | 0.030 |
Why?
|
Drug Synergism | 1 | 2020 | 1765 | 0.030 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2020 | 697 | 0.030 |
Why?
|
Cell Movement | 2 | 2020 | 5223 | 0.030 |
Why?
|
RNA | 2 | 2023 | 2728 | 0.030 |
Why?
|
Isoquinolines | 1 | 2017 | 354 | 0.030 |
Why?
|
Immunoglobulin Class Switching | 1 | 2017 | 289 | 0.030 |
Why?
|
Doxorubicin | 1 | 2022 | 2229 | 0.030 |
Why?
|
Internet | 1 | 2007 | 3123 | 0.030 |
Why?
|
Cytidine Deaminase | 1 | 2017 | 243 | 0.030 |
Why?
|
Recovery of Function | 1 | 2005 | 2994 | 0.030 |
Why?
|
Paclitaxel | 1 | 2022 | 1737 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2022 | 2925 | 0.030 |
Why?
|
Antigens, CD | 1 | 2005 | 4022 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 3710 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2204 | 0.030 |
Why?
|
Viral Load | 1 | 2023 | 3374 | 0.030 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2017 | 238 | 0.030 |
Why?
|
Transplantation Immunology | 1 | 2016 | 537 | 0.030 |
Why?
|
Dioxygenases | 1 | 2016 | 351 | 0.030 |
Why?
|
Fibroblasts | 1 | 2024 | 4180 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2022 | 3550 | 0.030 |
Why?
|
Ubiquitination | 1 | 2018 | 1010 | 0.030 |
Why?
|
DNA Replication Timing | 1 | 2013 | 35 | 0.030 |
Why?
|
Muscle, Smooth | 1 | 2017 | 930 | 0.030 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2013 | 96 | 0.030 |
Why?
|
bcl-Associated Death Protein | 1 | 2012 | 102 | 0.030 |
Why?
|
Gene Silencing | 1 | 2019 | 1502 | 0.030 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2012 | 85 | 0.030 |
Why?
|
Lymphotoxin-alpha | 1 | 1992 | 94 | 0.030 |
Why?
|
Chromosome Duplication | 1 | 2012 | 76 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2017 | 1524 | 0.020 |
Why?
|
DNA Repair | 1 | 2021 | 2051 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2023 | 4362 | 0.020 |
Why?
|
Amino Acid Substitution | 2 | 2010 | 1742 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2021 | 1600 | 0.020 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2012 | 275 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2016 | 3105 | 0.020 |
Why?
|
Phycoerythrin | 1 | 1991 | 9 | 0.020 |
Why?
|
Heart | 1 | 2024 | 4451 | 0.020 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2012 | 297 | 0.020 |
Why?
|
Viral Matrix Proteins | 1 | 2012 | 193 | 0.020 |
Why?
|
Urinary Bladder | 1 | 2017 | 1160 | 0.020 |
Why?
|
Point Mutation | 1 | 2016 | 1596 | 0.020 |
Why?
|
Immunoglobulin D | 1 | 1991 | 55 | 0.020 |
Why?
|
Cell Cycle | 1 | 2019 | 2942 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2012 | 323 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2017 | 1395 | 0.020 |
Why?
|
Dexamethasone | 1 | 2018 | 1965 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2067 | 0.020 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2012 | 355 | 0.020 |
Why?
|
Hippocampus | 1 | 2023 | 3783 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2021 | 2964 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 1992 | 1305 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2013 | 962 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2017 | 2730 | 0.020 |
Why?
|
Chemokine CXCL12 | 1 | 2012 | 457 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1622 | 0.020 |
Why?
|
Genetic Loci | 1 | 2019 | 2630 | 0.020 |
Why?
|
Macaca fascicularis | 1 | 1992 | 903 | 0.020 |
Why?
|
United States | 2 | 2021 | 73120 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7213 | 0.020 |
Why?
|
Infant | 2 | 2024 | 36496 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2016 | 2589 | 0.020 |
Why?
|
Myeloproliferative Disorders | 1 | 2016 | 614 | 0.020 |
Why?
|
Sample Size | 1 | 2013 | 851 | 0.020 |
Why?
|
Chimera | 1 | 2011 | 454 | 0.020 |
Why?
|
Placenta | 1 | 2018 | 1724 | 0.020 |
Why?
|
Threonine | 1 | 2010 | 274 | 0.020 |
Why?
|
Testis | 2 | 2004 | 783 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2018 | 1841 | 0.020 |
Why?
|
Family | 1 | 2020 | 3208 | 0.020 |
Why?
|
Reference Standards | 1 | 2012 | 1015 | 0.020 |
Why?
|
Metagenomics | 1 | 2012 | 476 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2015 | 1112 | 0.020 |
Why?
|
Histones | 1 | 2019 | 2596 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10784 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2012 | 1343 | 0.020 |
Why?
|
Antigens, Viral | 1 | 2012 | 992 | 0.020 |
Why?
|
Acute Disease | 1 | 2019 | 7245 | 0.020 |
Why?
|
Antibody Formation | 2 | 2003 | 1393 | 0.020 |
Why?
|
Age Factors | 1 | 2024 | 18477 | 0.020 |
Why?
|
Cell Count | 1 | 2011 | 1834 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9687 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2017 | 3734 | 0.020 |
Why?
|
Career Choice | 1 | 2012 | 769 | 0.020 |
Why?
|
Molecular Structure | 1 | 2010 | 1889 | 0.020 |
Why?
|
Genetic Testing | 1 | 2018 | 3586 | 0.020 |
Why?
|
Boronic Acids | 1 | 2009 | 915 | 0.020 |
Why?
|
Peptide Fragments | 2 | 2012 | 5151 | 0.020 |
Why?
|
Lung | 1 | 2023 | 10090 | 0.010 |
Why?
|
Computer Simulation | 1 | 2018 | 6278 | 0.010 |
Why?
|
Artifacts | 1 | 2013 | 1927 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 9066 | 0.010 |
Why?
|
Syndrome | 1 | 2010 | 3278 | 0.010 |
Why?
|
Precancerous Conditions | 1 | 2011 | 988 | 0.010 |
Why?
|
Lung Transplantation | 1 | 1993 | 1310 | 0.010 |
Why?
|
B-Cell Maturation Antigen | 1 | 2005 | 149 | 0.010 |
Why?
|
Pyrazines | 1 | 2009 | 1206 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15459 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1998 | 13025 | 0.010 |
Why?
|
Transfection | 1 | 2011 | 5767 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2012 | 2742 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3813 | 0.010 |
Why?
|
Drug Discovery | 1 | 2010 | 1062 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 1991 | 6241 | 0.010 |
Why?
|
Immune Tolerance | 1 | 2011 | 2324 | 0.010 |
Why?
|
Phosphorylation | 1 | 2012 | 8331 | 0.010 |
Why?
|
MicroRNAs | 1 | 2017 | 3806 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11249 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2002 | 1553 | 0.010 |
Why?
|
Isoantibodies | 1 | 2004 | 682 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2002 | 1992 | 0.010 |
Why?
|
Proteins | 1 | 2012 | 6009 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2025 | 36840 | 0.010 |
Why?
|
Pregnancy | 1 | 2018 | 30179 | 0.010 |
Why?
|
Brain | 1 | 2023 | 27439 | 0.010 |
Why?
|
Cell Membrane | 1 | 2005 | 3663 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2002 | 1479 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2001 | 2525 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2003 | 6320 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2001 | 4622 | 0.010 |
Why?
|
Aging | 1 | 2010 | 8762 | 0.010 |
Why?
|
Chronic Disease | 1 | 2004 | 9379 | 0.010 |
Why?
|
Risk Factors | 1 | 2010 | 74915 | 0.000 |
Why?
|